PAPER: Selective delivery of doxorubicin to EGFR+ cancer cells by Cetuximab-DNA conjugates
Delivery of the anticancer drug Cetuximab to EGFR+ cancer cells has recently been reported in ChemBioChem.
Delivery of the anticancer drug Cetuximab to EGFR+ cancer cells has recently been reported in ChemBioChem.